167 related articles for article (PubMed ID: 12963170)
1. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen.
dos Reis CM; de Melo NR; Meirelles ES; Vezozzo DP; Halpern A
Maturitas; 2003 Sep; 46(1):59-68. PubMed ID: 12963170
[TBL] [Abstract][Full Text] [Related]
2. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
[TBL] [Abstract][Full Text] [Related]
3. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of oestrogens: impact of the route of administration.
Ho KK; O'Sullivan AJ; Wolthers T; Leung KC
Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
[TBL] [Abstract][Full Text] [Related]
5. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women.
Hänggi W; Lippuner K; Jaeger P; Birkhäuser MH; Horber FF
Clin Endocrinol (Oxf); 1998 Jun; 48(6):691-9. PubMed ID: 9713556
[TBL] [Abstract][Full Text] [Related]
6. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
[TBL] [Abstract][Full Text] [Related]
7. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration.
Dick IM; Prince RL; Kelly JJ; Ho KK
Clin Endocrinol (Oxf); 1995 Aug; 43(2):219-24. PubMed ID: 7554318
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
[TBL] [Abstract][Full Text] [Related]
10. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
Gower BA; Nagy TR; Goran MI; Smith A; Kent E
J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
[TBL] [Abstract][Full Text] [Related]
11. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Mc Manus J; Mc Eneny J; Thompson W; Young IS
Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
[TBL] [Abstract][Full Text] [Related]
13. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
O'Sullivan AJ; Ho KK
J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
[TBL] [Abstract][Full Text] [Related]
15. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
16. Route-dependent endocrine and metabolic effects of estrogen replacement therapy.
O'Sullivan AJ; Ho KK
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1457-66. PubMed ID: 11202222
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in healthy, postmenopausal women.
Notelovitz M; John VA; Good WR
Menopause; 2002; 9(5):343-53. PubMed ID: 12218723
[TBL] [Abstract][Full Text] [Related]
18. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.
Torres-Santiago L; Mericq V; Taboada M; Unanue N; Klein KO; Singh R; Hossain J; Santen RJ; Ross JL; Mauras N
J Clin Endocrinol Metab; 2013 Jul; 98(7):2716-24. PubMed ID: 23678038
[TBL] [Abstract][Full Text] [Related]
20. Body composition and energy balance: lack of effect of short-term hormone replacement in postmenopausal women.
Anderson EJ; Lavoie HB; Strauss CC; Hubbard JL; Sharpless JL; Hall JE
Metabolism; 2001 Mar; 50(3):265-9. PubMed ID: 11230776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
